Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Mar 23;160(6):799–802.

Prevalence of Mycobacterium tuberculosis infection among injection drug users in Toronto

I D Rusen 1, L Yuan 1, M E Millson 1
PMCID: PMC1230158  PMID: 10189423

Abstract

BACKGROUND: Injection drug users are at increased risk of Mycobacterium tuberculosis infection and active tuberculosis (TB). The primary objective of this study was to determine the prevalence of M. tuberculosis infection among injection drug users in Toronto, as indicated by a positive tuberculin skin test result. An additional objective was to identify predictors of a positive skin test result in this population. METHODS: A cross-sectional study was carried out involving self-selected injection drug users in the city of Toronto. A total of 171 participants were recruited through a downtown Toronto needle-exchange program from June 1 to Oct. 31, 1996. RESULTS: Of 167 subjects tested, 155 (92.8%) returned for interpretation of their skin test result within the designated timeframe (48 to 72 hours). Using a 5-mm cut-off, the prevalence rate of positive tuberculin skin test results was 31.0% (95% confidence interval 23.8% to 38.9%). Birth outside of Canada and increasing age were both predictive of a positive result. INTERPRETATION: There is a high burden of M. tuberculosis infection in this population of injection drug users. The compliance observed with returning for interpretation of skin test results indicates that successful TB screening is possible among injection drug users.

Full Text

The Full Text of this article is available as a PDF (104.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bilgi C. Tuberculous infection in an urban population analysis of 1000 routine Mantoux tests. Can J Public Health. 1980 Sep-Oct;71(5):337–339. [PubMed] [Google Scholar]
  2. Brancker A., Enarson D. A., Grzybowski S., Hershfield E. S., Jeanes C. W. A statistical chronicle of tuberculosis in Canada: Part II. Risk today and control. Health Rep. 1992;4(3):277–292. [PubMed] [Google Scholar]
  3. Des Jarlais D. C., Hagan H., Friedman S. R., Friedmann P., Goldberg D., Frischer M., Green S., Tunving K., Ljungberg B., Wodak A. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995 Oct 18;274(15):1226–1231. doi: 10.1001/jama.274.15.1226. [DOI] [PubMed] [Google Scholar]
  4. Howard T. P., Solomon D. A. Reading the tuberculin skin test. Who, when, and how? Arch Intern Med. 1988 Nov;148(11):2457–2459. [PubMed] [Google Scholar]
  5. MacGregor R. R., Dunbar D., Graziani A. L. Tuberculin reactions among attendees at a methadone clinic: relation to infection with the human immunodeficiency virus. Clin Infect Dis. 1994 Dec;19(6):1100–1104. doi: 10.1093/clinids/19.6.1100. [DOI] [PubMed] [Google Scholar]
  6. Markowitz N., Hansen N. I., Wilcosky T. C., Hopewell P. C., Glassroth J., Kvale P. A., Mangura B. T., Osmond D., Wallace J. M., Rosen M. J. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med. 1993 Aug 1;119(3):185–193. doi: 10.7326/0003-4819-119-3-199308010-00002. [DOI] [PubMed] [Google Scholar]
  7. Menzies D., Chan C. H., Vissandjée B. Impact of immigration on tuberculosis infection among Canadian-born schoolchildren and young adults in Montreal. Am J Respir Crit Care Med. 1997 Dec;156(6):1915–1921. doi: 10.1164/ajrccm.156.6.9704017. [DOI] [PubMed] [Google Scholar]
  8. Perlman D. C., Salomon N., Perkins M. P., Yancovitz S., Paone D., Des Jarlais D. C. Tuberculosis in drug users. Clin Infect Dis. 1995 Nov;21(5):1253–1264. doi: 10.1093/clinids/21.5.1253. [DOI] [PubMed] [Google Scholar]
  9. Pesanti E. L. The negative tuberculin test. Tuberculin, HIV, and anergy panels. Am J Respir Crit Care Med. 1994 Jun;149(6):1699–1709. doi: 10.1164/ajrccm.149.6.7710481. [DOI] [PubMed] [Google Scholar]
  10. Stein S. C. Tuberculosis infection in a metropolitan city: an epidemiologic review. Am Rev Respir Dis. 1969 Feb;99(2):298–298. doi: 10.1164/arrd.1969.99.2.298. [DOI] [PubMed] [Google Scholar]
  11. Strathdee S. A., Patrick D. M., Currie S. L., Cornelisse P. G., Rekart M. L., Montaner J. S., Schechter M. T., O'Shaughnessy M. V. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997 Jul;11(8):F59–F65. doi: 10.1097/00002030-199708000-00001. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES